TALPHERA, INC. (TLPH) Gross Margin
- Gross margin · 12 months: Value (m); Formula and calculation Gross profit / revenue. Period ending 2019-12-31..
Gross margin
Overview →Financial period ending 2019-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | (m) | Gross profit / revenue. Period ending 2019-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | (m) | |
| Revenue | 2.29M USD | |
| Cost of products and services | 6.81M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2019-12-31 | (m) | $2.29M | $6.81M | (m) |
| 2019-09-30 | (m) | $2.43M | $6.43M | (m) |
| 2019-06-30 | (m) | $2.20M | $5.15M | (m) |
| 2019-03-31 | (m) | $2.07M | $4.09M | (m) |
| 2018-12-31 | (m) | $2.15M | $3.98M | (m) |
| 2018-09-30 | (m) | $2.28M | (m) | (m) |
| 2018-06-30 | (m) | $3.39M | (m) | (m) |
| 2018-03-31 | (m) | $5.23M | (m) | (m) |
| 2017-12-31 | (m) | $8.00M | (m) | (m) |
| 2017-09-30 | (m) | $13.69M | (m) | (m) |
| 2017-06-30 | (m) | $15.57M | (m) | (m) |
| 2017-03-31 | (m) | $17.44M | (m) | (m) |
| 2016-12-31 | (m) | $17.36M | (m) | (m) |
| 2016-09-30 | (m) | $12.65M | (m) | (m) |
| 2016-06-30 | (m) | $24.71M | (m) | (m) |
| 2016-03-31 | (m) | $22.11M | (m) | (m) |
| 2015-12-31 | (m) | $19.26M | (m) | (m) |
| 2015-09-30 | (m) | $17.76M | (m) | (m) |
| 2015-06-30 | (m) | $7.16M | (m) | (m) |
| 2015-03-31 | (m) | $5.30M | (m) | (m) |
| 2014-12-31 | (m) | $5.22M | (m) | (m) |
| 2014-09-30 | (m) | $32.60M | (m) | (m) |
| 2014-06-30 | (m) | $28.32M | (m) | (m) |
| 2014-03-31 | (m) | $28.66M | (m) | (m) |
| 2013-12-31 | (m) | $29.50M | (m) | (m) |
| 2013-09-30 | (m) | $3.57M | (m) | (m) |
| 2013-06-30 | (m) | $3.19M | (m) | (m) |
| 2013-03-31 | (m) | $3.00M | (m) | (m) |
| 2012-12-31 | (m) | $2.39M | (m) | (m) |
| 2012-09-30 | (m) | $1.34M | (m) | (m) |
| 2012-06-30 | (m) | $1.58M | (m) | (m) |
| 2012-03-31 | (m) | $1.40M | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |